The human microbiome lives on and in the human body.  These microorganisms influence everything from immunity to metabolism. In recent years, Paragon has been involved with the development of therapeutics to combat metabolic disorders, immunodeficiency, and rare diseases.  

We have established methods that utilize whole cell, re-engineered microbiota, as therapeutics from natural organisms.  Paragon has an active collaboration with biotech and pharmaceutical labs as well as university researchers and clinicians to further propel microbiome research and development through cGMP manufacturing of therapeutics.